Protagonist Therapeutics, Inc.
PTGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39 | -$35 | -$12 | $132 |
| Dep. & Amort. | $0 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $11 | $0 | $9 |
| Change in WC | $28 | -$4 | $125 | -$168 |
| Other Non-Cash | $9 | -$1 | $12 | -$3 |
| Operating Cash Flow | -$2 | -$29 | $125 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$161 | -$67 | -$214 | -$114 |
| Inv. Sales/Matur. | $103 | $123 | $120 | $106 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | -$59 | $55 | -$94 | -$9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6 | $3 | $12 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $4 |
| Financing Cash Flow | $6 | $3 | $11 | $4 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$55 | $29 | $42 | -$34 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $169 | $140 | $97 | $131 |
| End Cash | $114 | $169 | $140 | $97 |
| Free Cash Flow | -$2 | -$30 | $125 | -$29 |